REG - European Lithium Ltd - Issue of Securities

European LithiumAnnouncement

27/07/2020 08:25

RNS Number : 1499U
  
European Lithium Limited
  
27 July 2020
  
 

European Lithium Ltd
("European Lithium", "EUR" or "the Company")
ISSUE OF SECURITIES 
European Lithium Limited (ASX:EUR, FRA:PF8, VSE:ELI, NEX:EUR) (the Company) advises that 6,666,666 fully paid shares (the Shares) have been issued.  
 
In respect to the Shares, a total of 3,636,363 have been issued to Winance as announced on 5 March 2020. The full announcement can be seen at: 
https://www.asx.com.au/asxpdf/20200305/pdf/44fs6q67t8lgms.pdf
 
The balance of 3,030,303 shares have been issued to convert $90,909 of debt into equity.  
 
Application has been made for 6,666,666 shares to be admitted to trading on Aquis (Admission). Admission is expected to occur at 8:00am on or around 31st July 2020. Following Admission, the Company's issued share capital will comprise 668,959,875 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.  The above figure of 668,959,875 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
Tony Sage

Non-Executive Chairman
European Lithium Limited 
- END -
 
 
Visit the Company's website (www.europeanlithium.com) to find out more about the advanced Wolfsberg Lithium Project located in Austria.
For further information please contact:



European Lithium Ltd


+61 861 819 792




Tony Sage


ir@europeanlithium.com
 




NEX Corporate Adviser


+44 207 220 1666




James Joyce








James Sinclair-Ford







 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
NEXRRMRTMTBTMPM